SummerHaven Investment Management’s Medifast MED Stock Holding History

SummerHaven Investment Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$508K	Hold	47,835	–	–	0.27%	174
2026 Q1	$487K	Sell	47,835 -10,221	-18%	-$110K	0.3%	176
2025 Q4	$620K	Hold	58,056	–	–	0.35%	182
2025 Q3	$794K	Buy	58,056 +14,830	+34%	+$207K	0.46%	137
2025 Q2	$607K	Buy	43,226 +1,153	+3%	+$15.2K	0.4%	139
2025 Q1	$567K	Buy	42,073 +916	+2%	+$13.8K	0.4%	147
2024 Q4	$725K	Hold	41,157	–	–	0.45%	129
2024 Q3	$788K	Buy	+41,157	New	+$793K	0.48%	130
2024 Q2	–	Sell	-7,969	Closed	-$305K	–	193
2024 Q1	$305K	Buy	7,969 +166	+2%	+$8.04K	0.19%	188
2023 Q4	$525K	Buy	7,803 +160	+2%	+$11.1K	0.34%	179
2023 Q3	$572K	Buy	+7,643	New	+$678K	0.42%	162

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SummerHaven Investment Management's MED Position: Q2 2026 in Review

SummerHaven Investment Management held its Medifast (MED) position steady in Q2 2026 at 47,835 shares worth $508K. The position accounts for 0.27% of the portfolio, ranked #174.

SummerHaven Investment Management first reported a position in MED in Q3 2023 and has held it in 11 quarters since. The position peaked at $794K in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

SummerHaven Investment Management held 47,835 shares of Medifast worth $508K as of Q2 2026.
SummerHaven Investment Management left its Medifast share count unchanged in Q2 2026.
Medifast made up 0.27% of SummerHaven Investment Management's portfolio in Q2 2026, its #174 holding.
SummerHaven Investment Management first reported a position in Medifast in Q3 2023 and has held it in 11 quarters since.
SummerHaven Investment Management's Medifast position peaked at $794K in Q3 2025.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on SummerHaven Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.